{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T17:01:32Z","timestamp":1769706092311,"version":"3.49.0"},"reference-count":36,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T00:00:00Z","timestamp":1529366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T00:00:00Z","timestamp":1529366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Stat Methods Med Res"],"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:p>Goal Attainment Scaling is an assessment instrument to evaluate interventions on the basis of individual, patient-specific goals. The attainment of these goals is mapped in a pre-specified way to attainment levels on an ordinal scale, which is common to all goals. This approach is patient-centred and allows one to integrate the outcomes of patients with very heterogeneous symptoms. The latter is of particular importance in clinical trials in rare diseases because it enables larger sample sizes by including a broader patient population. In this paper, we focus on the statistical analysis of Goal Attainment Scaling outcomes for the comparison of two treatments in randomised clinical trials. Building on a general statistical model, we investigate the properties of different hypothesis testing approaches. Additionally, we propose a latent variable approach to generate Goal Attainment Scaling data in a simulation study, to assess the impact of model parameters such as the number of goals per patient and their correlation, the choice of discretisation thresholds and the type of design (parallel group or cross-over). Based on our findings, we give recommendations for the design of clinical trials with a Goal Attainment Scaling endpoint. Furthermore, we discuss an application of Goal Attainment Scaling in a clinical trial in mastocytosis.<\/jats:p>","DOI":"10.1177\/0962280218777896","type":"journal-article","created":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T00:50:41Z","timestamp":1529455841000},"page":"1893-1910","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":27,"title":["Statistical analysis of Goal Attainment Scaling endpoints in randomised trials"],"prefix":"10.1177","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4299-5881","authenticated-orcid":false,"given":"S","family":"Urach","sequence":"first","affiliation":[{"name":"Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CMW","family":"Gaasterland","sequence":"additional","affiliation":[{"name":"Pediatric clinical Research Office, Academic Medical Center, University of Amsterdam, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Posch","sequence":"additional","affiliation":[{"name":"Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Jilma","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Roes","sequence":"additional","affiliation":[{"name":"Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Rosenkranz","sequence":"additional","affiliation":[{"name":"Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JH","family":"Van der Lee","sequence":"additional","affiliation":[{"name":"Pediatric clinical Research Office, Academic Medical Center, University of Amsterdam, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4163-9236","authenticated-orcid":false,"given":"R","family":"Ristl","sequence":"additional","affiliation":[{"name":"Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2018,6,19]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21217"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.21544"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23905"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.12213"},{"key":"e_1_3_4_6_2","unstructured":"Committee for Medicinal Products for Human Use (CHMP). Guideline on the clinical investigation of medicinal products for the treatment of Duchenne and Becker muscular dystrophy http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2015\/12\/WC500199239.pdf (accessed 22 May 2018)."},{"key":"e_1_3_4_7_2","unstructured":"US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER). Duchenne muscular dystrophy and related dystrophinopathies: Developing drugs for treatment \u2013 guidance for industry https:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM450229.pdf (accessed 22 May 2018)."},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01530764"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.2340\/16501977-0383"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.2007.00550.x"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(93)90110-M"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269215506070793"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.5014\/ajot.47.4.349"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2011.01.003"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1177\/004005990503700401"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10803-012-1446-7"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-016-0205-4"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2012.03.005"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0012162206000387"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.2007.00823.x"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.73.5.500"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1080\/0013188960380204"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1080\/1034912980450207"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2015.08.424"},{"key":"e_1_3_4_25_2","unstructured":"US Department of Health and Human Services Food and Drug Administration. Patient-focused drug developlment public workshop on guidance 1 \u2013 collecting comprehensive and representative input \u2013 discussion document https:\/\/www.fda.gov\/Drugs\/NewsEvents\/ucm574725.htm (accessed 4 March 2018)."},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/ptj\/73.10.651"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1159\/000178757"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/73.1.13"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-1809.1936.tb02137.x"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v015.i02"},{"key":"e_1_3_4_31_2","doi-asserted-by":"crossref","unstructured":"Senn S. Cross-over trials in clinical research 2nd ed. West Sussex England: John Wiley & Sons 2002.","DOI":"10.1002\/0470854596"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002266"},{"key":"e_1_3_4_33_2","volume-title":"Statistical methods","author":"Snedecor GW","year":"1967","unstructured":"Snedecor GW, Cochran WG. Statistical methods, Ames, Iowa, USA: Iowa State University Press, 1967."},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780141309"},{"key":"e_1_3_4_35_2","volume-title":"Statistics for experimenters: an introduction to design, data analysis, and model building","author":"Box GE","year":"1978","unstructured":"Box GE, Hunter WG, Hunter JS. Statistics for experimenters: an introduction to design, data analysis, and model building, New York, NY: John Wiley and Sons, 1978."},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6288"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.19.2554"}],"container-title":["Statistical Methods in Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0962280218777896","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0962280218777896","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0962280218777896","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T03:48:08Z","timestamp":1762400888000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0962280218777896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,19]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["10.1177\/0962280218777896"],"URL":"https:\/\/doi.org\/10.1177\/0962280218777896","relation":{},"ISSN":["0962-2802","1477-0334"],"issn-type":[{"value":"0962-2802","type":"print"},{"value":"1477-0334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,19]]}}}